BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30738455)

  • 1. [Clinical Analysis of Serum Calcium Level in 86 Cases of Newly Diagnosed Multiple Myeloma].
    Zhang J; Yang J; Wang PP; Zhang PP; Yuan MW; Ma ZZ; Zhou Q; Wei T; Mao XL; Li M; Zhao L; Zhang H; Xi YM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):104-109. PubMed ID: 30738455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical Significance of Serum ADA Combined with GLB, CREA, β
    Qian H; Yuan HL; Zhang T; Yang YW; Feng JF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):780-788. PubMed ID: 38926967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical Significance of Serum Free Light Chain and Its κ/λ Ratio in Patients with Multiple Myeloma].
    Zhao D; Jiang JQ; Lin L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1173-1178. PubMed ID: 31418375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of Serum Free Light Chain on Renal Function and Prognosis in Patients with Newly Diagnosed Multiple Myeloma].
    Chen XD; Luo XF; Zu YP; Ye H; Li LL; Chen QL; Xie WZ; Yang T; Hu JD; Wei LX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1862-1868. PubMed ID: 31839051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical Significance of Corrected Serum Calcium in 320 Patients with Multiple Myeloma].
    Xu ZZ; Wu SQ; Wang QQ; Ye YM; Ma XM; Zhan R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1058-1062. PubMed ID: 28823268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical Characteristics and Prognosis of Multiple Myeloma Patients with Different Results of Blood Separation].
    Zhang JY; Fan H; Zhang J; Zhao Q; Xu D; You FF; Guo L; Zhang H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):547-552. PubMed ID: 32319394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Predictive Value of Pre-treatment Serum Uric Acid Level for Prognosis in Newly Diagnosed Patients with Multiple Myeloma].
    Xu SQ; Zhao P; Wang ZH; Deng H; Zhang L; Wei J; Zou XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1216-1223. PubMed ID: 34362505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features of multiple myeloma patients with renal insufficiency as the initial clinical manifestation].
    Ma RX; Li ZL; Wang T; Wu GH; Wu YL
    Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):552-5. PubMed ID: 27531272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical characteristics of bone disease in multiple myeloma and clinical significance of monitoring bone metabolic markers].
    Chu B; Lu MQ; Wu MQ; Shi L; Fu LN; Gao S; Fang LJ; Xiang QQ; Bao L
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1424-9. PubMed ID: 27266350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercalcemia caused by humoral effects and bone damage indicate poor outcomes in newly diagnosed multiple myeloma patients.
    Bao L; Wang Y; Lu M; Chu B; Shi L; Gao S; Fang L; Xiang Q
    Cancer Med; 2020 Dec; 9(23):8962-8969. PubMed ID: 33145966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients].
    Deng SH; Xu Y; Mai YJ; Wang YF; Zhao YZ; Zou DH; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):217-21. PubMed ID: 18843972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of the serum phosphorus level and its relationship with other prognostic factors in multiple myeloma.
    Umeda M; Okuda S; Izumi H; Nagase D; Fujimoto Y; Sugasawa Y; Arai C; Natori K; Katoh M; Kuraishi Y
    Ann Hematol; 2006 Jul; 85(7):469-73. PubMed ID: 16528526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of related risk factors and reversal value of renal injury in elderly patients with multiple myeloma.
    Ling W; Yu W; Sun H; Lv M
    J BUON; 2017; 22(3):735-740. PubMed ID: 28730783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of 1027 patients with newly diagnosed multiple myeloma.
    Kyle RA; Gertz MA; Witzig TE; Lust JA; Lacy MQ; Dispenzieri A; Fonseca R; Rajkumar SV; Offord JR; Larson DR; Plevak ME; Therneau TM; Greipp PR
    Mayo Clin Proc; 2003 Jan; 78(1):21-33. PubMed ID: 12528874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium and phosphorus metabolism in stable renal transplant recipients.
    Khosroshahi HT; Shoja MM; Azar SA; Tubbs RS; Safa J; Etemadi J; Ardalan MR
    Exp Clin Transplant; 2007 Dec; 5(2):670-2. PubMed ID: 18194119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features and survival of Chilean patients with multiple myeloma].
    Conté L G; Figueroa M G; Lois V V; Cabrera C ME; León R A; García L H; Rojas R H
    Rev Med Chil; 2007 Sep; 135(9):1111-7. PubMed ID: 18064364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influencing factors and clinical significance of severe hypocalcemia in patients with extremely severe burns in early stage].
    Wu J; Zhang Q; Liu J; Tang JJ; Zheng JX
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):203-207. PubMed ID: 29690737
    [No Abstract]   [Full Text] [Related]  

  • 18. Syndecan-1 in multiple myeloma: relationship to conventional prognostic factors.
    Aref S; Goda T; El-Sherbiny M
    Hematology; 2003 Aug; 8(4):221-8. PubMed ID: 12911939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum albumin level is a significant prognostic factor reflecting disease severity in symptomatic multiple myeloma.
    Kim JE; Yoo C; Lee DH; Kim SW; Lee JS; Suh C
    Ann Hematol; 2010 Apr; 89(4):391-7. PubMed ID: 19844712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Levels of Interleukin-1β and Disease Progression in Multiple Myeloma Patients: A Case and Control Study.
    Teimuri Nobari S; Rasmi Y; Khadem Ansari MH
    Asian Pac J Cancer Prev; 2022 Sep; 23(9):2937-2942. PubMed ID: 36172655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.